March 31, 2020 — Two British companies at the leading edge of medical imaging technology are working together on a plan to fast-track the diagnosis of COVID-19 in NHS hospitals using artificial intelligence analysis of chest X-rays.

March 31, 2020 — In a letter to its members, Society of Nuclear Medicine and Molecular Imaging (SNMMI) President Vasken Dilsizian, M.D., announced the development of a COVID-19 Resource Center

March 31, 2020 — An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found.

March 30, 2020 — In the wake of the COVID-19 pandemic, a team of radiation oncologists from the U.S. and U.K. is recommending a new framework for making decisions about radiation therapy for prostate cancer patients that weighs risks and benefits during these difficult times.

March 30, 2020 — Women undergoing radiotherapy for many cancers are more likely than men to be cured, but the side effects are more brutal, according to one of Australia’s most experienced radiation oncology medical physicists.

March 30, 2020 — The medical imaging community around the world is uniting to help address the COVID-19 pandemic.

March 30, 2020 — Lunit, a medical AI software company that develops AI-powered analysis of lung diseases via chest X-ray images, today announced that it will be releasing its software online, free of charge, to help healthcare professionals manage coronavirus.

Phase III response to the COVID-19 public health emergency (PHE) CARES Act signed into law #CARESAct #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

On March 27, the House of Representatives approved a historic $2 trillion stimulus package and sent it to President Trump for his signature, who then signed it into law. The package includes $100 billion to provide monetary assistance to the nation's struggling hospitals coping with the novel coronavirus (COVID-19) pandemic.

March 27, 2020 — Based on recent scientific research, diagnostic X-ray computed tomography (CT) is able to detect COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2), in individuals with high clinical suspicion of the virus — even in cases with negative initial DNA tests.

March 27, 2020 — PaxeraHealth has spent years building and bettering its solutions and has been poised to respond to today's world pandemic within a matter of days. At this critical time, the company has focused its efforts on helping frontline healthcare providers beat this aggressive virus.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now